Nitrates
Key Points
- Nitrates relieve angina by vasodilation that improves myocardial oxygen supply-demand balance.
- Nitroglycerin is used for acute angina relief and prophylaxis before exertional triggers.
- Sublingual nitroglycerin may be repeated every 5 minutes up to 3 doses while reassessing symptoms and blood pressure.
- If symptoms are not improved after the first dose or worsen, call 911 immediately.
- Concurrent use with sildenafil or similar PDE-5 inhibitors can cause severe hypotension and is contraindicated.
- Store sublingual tablets in the original airtight glass container and protect from heat/light.
Pathophysiology
Angina reflects myocardial hypoxia from reduced coronary perfusion and/or increased oxygen demand. Nitrates relax vascular smooth muscle, especially venous capacitance vessels and coronary vessels, reducing preload and myocardial workload while improving perfusion.
Nitrates are one antianginal option; beta-blockers and calcium channel blockers may also be used to reduce oxygen demand.
Classification
- Sublingual nitroglycerin: Rapid PRN rescue for acute stable-angina episodes.
- Extended-release oral forms: Ongoing antianginal prevention pathways.
- Topical/transdermal forms: Paste or patch for sustained symptom prevention.
- Intravenous nitrates: Higher-acuity monitored settings.
Nursing Assessment
NCLEX Focus
Prioritize symptom response and hemodynamic safety after each dose, with immediate emergency escalation when pain does not improve promptly.
- Assess chest-pain characteristics, baseline blood pressure, heart rate, and perfusion before administration.
- Reassess chest pain and blood pressure after each sublingual dose.
- Screen for absolute interaction risk with recent PDE-5 inhibitor use (for example sildenafil-class agents within about 24 hours in this source context).
- Assess contraindication patterns including severe anemia, increased intracranial pressure, hypersensitivity, and circulatory failure.
- In this source context, avoid nitrate use in pregnancy/breastfeeding unless specialist-directed risk-benefit review supports use.
Nursing Interventions
- For sublingual administration, place tablet under tongue and allow it to dissolve; do not chew or crush.
- Keep client seated during sublingual dosing because hypotension/dizziness can occur.
- Avoid eating or smoking during sublingual administration because absorption can be altered.
- Dose pattern: one sublingual tablet every 5 minutes, maximum three tablets in 15 minutes unless protocol/order differs.
- Call 911 if symptoms are not improved after the first dose, worsen, or persist after the full initial series.
- Teach prophylactic use about 5-10 minutes before activities known to trigger exertional angina.
- For transdermal paste/patch forms, apply to clean dry upper-body/arm skin and rotate sites to reduce skin irritation.
- Store sublingual tablets in original airtight glass container and protect from heat/light exposure.
PDE-5 Inhibitor Interaction
Do not administer nitrates with sildenafil-class medications due to risk of life-threatening hypotension.
Pharmacology
| Drug/Class | Typical Clinical Use | Key RN Considerations |
|---|---|---|
| Nitroglycerin (sublingual) | Acute stable-angina episode relief | 1 dose every 5 minutes up to 3 doses, BP check after each dose, seated dosing, 911 escalation if not improved after first dose/worsening |
| Nitroglycerin (prophylactic use) | Pre-exertional angina prevention | Administer before trigger activity (about 5-10 minutes), reinforce carry-and-storage safety |
| Nitroglycerin paste/patch | Sustained antianginal prevention | Apply to clean dry skin, rotate sites, follow product timing instructions |
Clinical Judgment Application
Clinical Scenario
A client with known stable angina reports chest pain at rest and receives the first sublingual nitroglycerin dose.
- Recognize Cues: Active chest pain plus nitrate exposure risk for hypotension.
- Analyze Cues: Immediate priority is determining early response and whether emergency escalation is needed.
- Prioritize Hypotheses: Persistent pain after first dose may represent unstable ischemia requiring emergency care.
- Generate Solutions: Reassess pain and BP promptly, prepare repeat dose if indicated, and activate EMS per protocol threshold.
- Take Action: Keep client seated, administer per timing rules, and call 911 without delay if no early improvement/worsening.
- Evaluate Outcomes: Pain and hemodynamics stabilize or emergency pathway is activated rapidly.
Related Concepts
- coronary-artery-disease - Nitrates are core antianginal therapy in CAD symptom pathways.
- calcium-channel-blockers - Alternative/add-on antianginal class.
- beta-blockers - Additional myocardial oxygen-demand reduction strategy.
- phosphodiesterase-5-inhibitors - Absolute interaction concern due to severe hypotension risk.
Self-Check
- What reassessment is required after each sublingual nitroglycerin dose?
- When should emergency help be activated during a nitrate rescue sequence?
- Why must nitrate storage and administration technique teaching be explicit?